Schlumberger Limited (NYSE:SLB) is now worth $57.81B thanks to 0.22% gain in recent trade and currently has a price tag of $41.74. The shares traded as low as $40.69 and had $41.77 an intraday high earlier Friday. Trading activity significantly weakened as the volume at ready counter decreased to 13,328,581 shares versus 18,483,756 in average daily trading volume over the past 20 days. So far this year, the volume has averaged about 16,098,313 shares. The stock is now 19.29% above against its bear-market low of $34.99 on December 26, 2018. It has retreated -92.5% since it’s 52-week high of $80.35 reached in January. Now the market price is down -44.79% on the year and up 15.69% YTD.
SLB’s 50 day simple moving average (SMA 50) price is $43.85 and its 200-day simple moving average (SMA 200) price is $60.03. The company’s stock currently has a total float of 1.38B shares. Its weekly volatility is hovering around 2.66% and felt 3.62% volatility in price over a month. On the upside, the share price will test short term resistance at around $42.11. On a downside, the stock is likely to find some support, which begins at $41.03. The failure to get near-term support could push it to $40.32.
Separately, it has been reported that multiple insider activity took place at Schlumberger Limited (SLB). EVP Wells Schorn Patrick acquired 10,000 shares for $35,000 in transaction occurred on 2018/12/20. After making this transaction, the EVP Wells owns a direct stake of 375,500 shares, worth $1,460,900, as per the last closing price. On 2018/10/30 Ayat Simon, CFO at SLB, dumped 60,000 shares at an average price of $56.6 per share. The selling total is valued at $8,515,294.
Director, Marks Michael E had invested in 8,000 shares for $68,021 through a trade on 2018/09/06. Following this activity, the insider holds 482,480 shares worth $2,839,197 as of recent close. Wall Street’s most bullish Schlumberger Limited (NYSE:SLB) analysts are predicting the share price to blow past $90 per share during the next 12 months. The current median share price forecast by them is $58, suggesting that the stock could increase 38.96% in that time frame. The average price target of $57.77 calls for a nearly 38.4% increase in the stock price.
It had seen a negative analyst call from Credit Suisse, which downgraded the stock from Outperform to Neutral on December 19. Analysts at JP Morgan, shed their positive views on December 11 by lowering it fromOverweight to Neutral. Brokerage firm BofA/Merrill, looks cautious as they stick to prior recommendation of Buy, in a call on December 03. However, they did change the target price from $69 to $52. HSBC Securities analysts came out with bullish views on November 26 when the call was made. They think the stock is now Buy compared to to their prior call for Hold.
Moreover, it trades for 22.51 times the next 12 months of expected earnings. Also, it is trading at rather expensive levels at just over 1.58x price/book and 1.76x price/sales. Compared to others, Schlumberger Limited is in a different league with regards to profitability, having net margins of -2%. To put some perspective around this, the industry’s average net margin is -26.53%. SLB’s ROE is -1.8%, which is also considerably worse than the industry’s ROE of 7.15%. It’s also very liquid in the near term, with a current ratio of 1.1. The stock has a debt/capital of 0.48.
Shares of Schlumberger Limited (SLB) have dropped -28.6% since the company’s Mar-19 earnings report. Over the past 12 fiscal quarters, Schlumberger Limited (NYSE:SLB) has topped consensus earnings estimates in 7 quarters (58%), missed earnings in 1 quarters (8%), whereas at 4 occasion EPS met analyst expectations. SLB last reported earnings on October 19, 2018 when it released Sep-18 results that exceeded expectations. The company raked in $0.46 per share, -67.38% change on the same period last year. That was better than consensus for $0.45. Revenue for the recent quarter stood at $8.5 billion, up 8% on last year and below the $8.58 billion predicted by analysts. For this quarter, Wall Street analysts forecast revenue in a range of $7.51 billion to $8.45 billion, which should be compared with $8.77 billion generated last year. EPS is seen in a range of $0.23 to $0.54, against the $0.71 reported a year ago.